Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT00831480
Title Everolimus(RAD001) For Advanced Renal Cell Carcinoma(RCC)Before Kidney Removal
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Gilad Amiel
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
UT Southwestern Medical Center Dallas Texas 75390 United States Details
Baylor College of Medicine Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field